Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Top Links You Must Click On


Sanford-Burnham Medical Research Institute Announces John C. Reed, M.D., Ph.D., Resigns as Chief Executive Officer to Accept Position as Global Head of Pharma Research and Early Development for Roche

LA JOLLA, Calif. and ORLANDO, Fla., Jan. 15, 2013 /PRNewswire/ -- Sanford-Burnham Medical Research Institute Board of Directors (trustees) announced today that John C. Reed, M.D., Ph.D. has accepted the position of Head of Roche Pharma Research and Early Development and member of the Corporate Executive Committee. Kristiina Vuori, M.D., Ph.D., president of Sanford-Burnham, will assume all leadership responsibilities on an interim basis.

"John has led Sanford-Burnham through a decade of tremendous success and growth, particularly in translational research, and we wish him the best as he moves to a new stage of his career," said M. Wainwright Fishburn, Jr., chairman of Sanford-Burnham's Board of Trustrees. "We have a strong foundation for continued growth, and we have complete confidence in Kristiina's ability to lead through the management transition."

Added Dr. Reed, "I am grateful to have led Sanford-Burnham over the past decade, especially in the growth of the Institute's work in translational research. While I am sad to be leaving the Institute, I look forward to the potential for collaborations in the future between the two organizations. I am confident in the financial strength of the Institute following the strongest year of grant revenue in its history, as well as in Dr. Vuori's ability to lead through the time ahead. We have worked side-by-side in leading Sanford-Burnham, so she is uniquely qualified to guide a smooth transition and continued excellence."

Under Dr. Reed's leadership, Sanford-Burnham, which is headquartered in La Jolla, Calif., opened a second research campus as part of the Medical City created at Lake Nona, in Orlando, Fla. In addition, the Institute ranked number one worldwide for scientific impact, as measured in citations per publication, in the field of biology and biochemistry for the decade of 1999-2009. It also became the third-largest recipient of NIH funding among all laboratory research-based organizations in the nation, and second most efficient in innovation, based on patents issued per grant dollars awarded. In 2010, the Institute received its largest single donation of $50 million from T. Denny Sanford, for whom the Institute was renamed. Following the management transition, Dr. Reed will retain his association with the Institute through an adjunct professor appointment.

"This institute has become a world-leader in research and early-stage drug discovery, with Dr. Reed overseeing the expansion of our research centers and collaborations with industry, research and government partners," said Malin Burnham, Honorary Trustee of Sanford-Burnham Medical Research Institute. "We are very proud of our accomplishments during the past decade under John's leadership."

Added T. Denny Sanford, "I recognized the strength of this institute at the time of my donation in 2010, and I continue to have the utmost confidence in its future and direction. I look forward to further growth under the leadership of Dr. Vuori and the Institute's Board of Trustees."

Dr. Vuori is president of Sanford-Burnham, director of Sanford-Burnham's National Cancer Institute (NCI)-designated Cancer Center, the Pauline & Stanley Foster Presidential Chair and Jeanne & Gary Herberger Leadership Chair in Cancer Research. Her research at Sanford-Burnham is primarily focused on understanding the molecular mechanisms of cancer metastasis in order to find methods to prevent this process that accounts for more than 90 percent of cancer deaths. She was appointed to the faculty of Sanford-Burnham in 1996, director of Sanford-Burnham's NCI-designated Cancer Center in 2006 and has been the Institute's president since April 2010.

"Sanford-Burnham's ability to combine outstanding basic research with competency in drug discovery is the Institute's biggest differentiator in the non-profit world," said Duane Roth, vice chairman of Sanford-Burnham's Board of Trustrees. "These capabilities that Drs. Reed and Vuori have built in partnership offer several unique and exciting opportunities for the Institute in the future."

About Sanford-Burnham Medical Research Institute

Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. The Institute consistently ranks among the top five organizations worldwide for its scientific impact in the fields of biology and biochemistry (defined by citations per publication) and currently ranks third in the nation in NIH funding among all laboratory-based research institutes. Sanford-Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is especially known for its world-class capabilities in stem cell research and drug discovery technologies. Sanford-Burnham is a U.S.-based, non-profit public benefit corporation, with operations in San Diego (La Jolla), California and Orlando (Lake Nona), Florida. For more information, news, and events, please visit us at sanfordburnham.org.

Media Contact:
Ian Stone or Tony Russo
Russo Partners
Tel: +1 619-308-6541
ian.stone@russopartnersllc.com
tony.russo@russopartnersllc.com

SOURCE Sanford-Burnham Medical Research Institute

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Enterprise Open Source Magazine Latest Stories . . .
What are the benefits of using an enterprise-grade orchestration platform? In their session at 15th Cloud Expo, Jeff Tegethoff, CEO of Appcore, and Kedar Poduri, Senior Director of Product Management at Citrix Systems, will take a closer look at the architectural design factors neede...
StackIQ offers a comprehensive software suite that automates the deployment, provisioning, and management of Big Infrastructure. With StackIQ’s software, you can spin up fully configured big data clusters, quickly and consistently — from bare-metal up to the applications layer — and ma...
Here’s the presentation I gave at the Linux Foundation’s CloudOpen in Dusseldorf on October 13, 2014 titled Mixing Your Open Source Cloud Cocktail Add two parts virtualization, one part orchestration add a little networking shake and pour. Unfortunately cloud computing isn’...
There's fog coming to the world of IT. Some people are calling this "The Cloud." This fog turns everything inside out. It will take your monolithic applications, the guts of which are contained within large bodies of code, and break them apart so that discrete units of functionality a...
In his session at 15th Cloud Expo, Mark Hinkle, Senior Director, Open Source Solutions at Citrix Systems Inc., will provide overview of the open source software that can be used to deploy and manage a cloud computing environment. He will include information on storage, networking(e.g.,...
When I took my operating systems fundamentals course in college I was taught that an operating system provides very specific capabilities that provides users with access compute resources for building and running applications. Over time as networking capabilities and bandwidth increase...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE